Page 6 - Pipeline Overview News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pipeline overview. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pipeline Overview Today - Breaking & Trending Today

atai Life Sciences Announces R&D Day Agenda

NEW YORK and BERLIN, Oct. 20, 2022 (GLOBE NEWSWIRE) atai Life Sciences N.V. (NASDAQ: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders ....

Stephen Bardin , Srinivas Rao , Allan Malievsky , Gerard Sanacora , Rolando Gutierrez Esteinou , Life Sciences Rd Strategy , Exchange Commission , Early Development , Icahn School Of Medicine At Mount Sinai , Yale Depression Research Clinic , Life Sciences , Neokee Pharma Consulting , Yale Interventional Psychiatry Service , Program Updates , Investor Relations , Life Science Rd Day , Pipeline Overview , Regulatory Landscape , Heather Berlin , Clinical Psychologist , Associate Clinical Professor , Icahn School , Yale School , Depression Research Clinic , Interventional Psychiatry , Chief Scientific Officer ,

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences Announces R&D Day Agenda

Investegate announcements from atai Life Sciences, atai Life Sciences Announces R&D Day Agenda ....

Stephen Bardin , Srinivas Rao , Allan Malievsky , Gerard Sanacora , Rolando Gutierrez Esteinou , Life Sciences Rd Strategy , Exchange Commission , Yale Depression Research Clinic , Early Development , Icahn School Of Medicine At Mount Sinai , Life Sciences , Neokee Pharma Consulting , Life Sciences Announces Rd Day Agenda , Yale Interventional Psychiatry Service , Program Updates , Life Sciences Announces Rd Day , Investor Relations , Life Science Rd Day , Pipeline Overview , Florian Brand , Regulatory Landscape , Heather Berlin , Clinical Psychologist , Associate Clinical Professor , Icahn School , Yale School ,

Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update

Share this article
Share this article
ENGLEWOOD, Colo., March 3, 2021 /PRNewswire/ Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today reported annual financial results for the year ended December 31, 2020 and provided a corporate overview / business update.
Mr. Michael Macaluso, President and CEO, noted, The FDA has recently responded to our requests to expand our IV and Inhalation Covid-19 studies, utilizing Ampion, by recommending we conduct a randomized, double-blinded, placebo-controlled Phase II trial in each. They also indicated that their recommended trial design for both will allow for an effective and efficient review of data results, determine the safety and statistical significance and effectiveness of Ampion in comparison to Standard of Care, all of which are necessary for the FDA to objectively determine that the known and poten ....

United States , Katie Kennedy , Holli Cherevka , Daniel Stokely , Michael Macaluso , Joe Hassett , Conference Call For The Investment Community , Company Contacts , Exchange Commission On , Small Business Administration , Exchange Commission , Ampio Pharmaceuticals , American Company Guidelines Sections , Payroll Protection Funding Program , Clinical Research Organization , Paycheck Protection Program , Ampio Pharmaceuticals Inc , Chief Executive Officer , David Bar Or , Chief Operating Officer , Chief Financial Officer , Conference Call , Investment Community , Pipeline Overview , Emergency Use Authorization , Special Protocol Assessment ,